|
CAS-Nr. | 57852-57-0 |
Bezeichnung: | (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacen-5,12-dionhydrochlorid |
Englisch Name: | Idarubicin hydrochloride |
Synonyma: | (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacen-5,12-dionhydrochlorid Zavedos;(7S,9S)-;4-DMD HCl;4-DMDR) HCl;IDARUBICIN HCL;Idarubicin HCI;Idarubicin HCl API;Idarubicin hcl USP/EP;IDARUBICIN HYDROCHLORIDE;Idarubicin HCL for research |
CBNumber: | CB3727751 |
Summenformel: | C26H28ClNO9 |
Molgewicht: | 533.95 |
MOL-Datei: | 57852-57-0.mol |
|
|
|
|
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacen-5,12-dionhydrochlorid physikalisch-chemischer Eigenschaften |
|
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacen-5,12-dionhydrochlorid Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften Orange Solid |
|
Verwenden Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL |
|
Verwenden Orally active anthracycline; analog of Daunorubicin. Antineoplastic |
|
R-Sätze Betriebsanweisung: R60:Kann die Fortpflanzungsfähigkeit beeinträchtigen. R61:Kann das Kind im Mutterleib schädigen. R28:Sehr giftig beim Verschlucken. R40:Verdacht auf krebserzeugende Wirkung. |
|
S-Sätze Betriebsanweisung: S53:Exposition vermeiden - vor Gebrauch besondere Anweisungen einholen. S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen). S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen. S22:Staub nicht einatmen. |
|
|
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacen-5,12-dionhydrochlorid Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacen-5,12-dionhydrochlorid Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 86)Lieferanten |
|
|
|
|
DNA metabolism
DNA Synthesis Inhibitors
57852-57-0
Apoptosis and Cell Cycle
BioChemical
Cell Biology
Cell Signaling and Neuroscience
IDARUBICIN HCL
IDARUBICIN HYDROCHLORIDE
4-demethoxy-daunomycihydrochloride
4-demethoxydaunorubicinhydrochloride
C26H28ClNO9
C26H27NO9HCl
(7s-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
4-DMD HCl
5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S,9S)-
5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S-cis)-
Zavedos
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione hydrochloride
API
Idarubicin HCL for research
(7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Hydrochloride
Drug Analogues
Intermediates & Fine Chemicals
Pharmaceuticals
DMDR, Idamycin, IMI-30, (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
C26H27NO9xHCL
(7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride
5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro- 6,9,11-trihydroxy-, hydrochloride, (7S-cis)-
Daunomycin, 4-demethoxy-, hydrochloride
Idarubicin Hydrochloride(NSC-256439, IdaMycin)
Idarubicin hcl USP/EP
C26H27NO9ClH
Idarubicin Hydrochloride (50 mg)
(7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-aMino-5-hydroxy-6-Methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
(7S,9S)-
Idarubicin HCl API
Idamycin, Zavedos, 4-demethoxydaunorubicin
Anti-cancer&immunity
Idarubicin HCI
5,12-Naphthacenedione,9-acetyl-7-[(3-aMino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-,hydrochloride (1:1), (7S,9S)-
(7S,9S)-9-acetyl-7-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
4-demethoxydaunorubicin (NSC256439
4-DMDR) HCl
|